Absci Corporation – NASDAQ:ABSI
Founder-led company
Absci stock price today
$2.65
-0.12
-4.33%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 5 hours
Absci stock price monthly change
-31.27%
month
Absci stock price quarterly change
-31.27%
quarter
Absci stock price yearly change
-42.17%
year
Absci key metrics
Market Cap | 332.50M |
Enterprise value | 120.38M |
P/E | -1.64 |
EV/Sales | 15.90 |
EV/EBITDA | -0.84 |
Price/Sales | 21.84 |
Price/Book | 0.60 |
PEG ratio | 0.55 |
EPS | -1.16 |
Revenue | 5.34M |
EBITDA | -75.62M |
Income | -109.18M |
Revenue Q/Q | -29.23% |
Revenue Y/Y | -13.71% |
Profit margin | -2154.84% |
Oper. margin | -762.29% |
Gross margin | 13.24% |
EBIT margin | -762.29% |
EBITDA margin | -1414.38% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAbsci stock price history
Absci stock forecast
Absci financial statements
| Jun 2023 | 3.36M | -41.67M | -1237.66% |
|---|---|---|---|
| Sep 2023 | 744K | -21.99M | -2956.18% |
| Dec 2023 | 338K | -23.54M | -6965.98% |
| Mar 2024 | 898K | -21.97M | -2447.1% |
| Sep 2025 | 14.2M | -11.57M | -81.49% |
|---|---|---|---|
| Oct 2025 | 13.35M | -8.94M | -67.01% |
| Dec 2025 | 1.3M | 0 | |
| Dec 2025 | 10M | -12.92M | -129.21% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 254153000 | 38.75M | 15.25% |
|---|---|---|---|
| Sep 2023 | 236344000 | 39.92M | 16.89% |
| Dec 2023 | 234480000 | 58.30M | 24.87% |
| Mar 2024 | 274898000 | 34.79M | 12.66% |
| Jun 2023 | -19.23M | 70.15M | -1.22M |
|---|---|---|---|
| Sep 2023 | -10.36M | 20.13M | -924K |
| Dec 2023 | -14.92M | 18.95M | -1.23M |
| Mar 2024 | -17.86M | -76.68M | 81.18M |
Absci alternative data
| Aug 2023 | 193 |
|---|---|
| Sep 2023 | 193 |
| Oct 2023 | 193 |
| Nov 2023 | 193 |
| Dec 2023 | 193 |
| Jan 2024 | 193 |
| Feb 2024 | 193 |
| Mar 2024 | 155 |
| Apr 2024 | 155 |
| May 2024 | 155 |
| Jun 2024 | 155 |
| Jul 2024 | 155 |
Absci other data
22.73%
-23.16%
of ABSI is owned by hedge funds
44
-33
20.65M
-21.16M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2024 | 222222 | 0 |
| May 2024 | 0 | 3100000 |
| Jun 2024 | 0 | 19859 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | JONASSON ZACHARIAH officer: CFO / CBO | Common Stock | 28,700 | $3.39 | $97,293 | ||
Sale | JONASSON ZACHARIAH officer: CFO / CBO | Common Stock | 19,859 | $4.98 | $98,898 | ||
Option | JONASSON ZACHARIAH officer: CFO / CBO | Stock Option (right to buy) | 28,700 | $3.39 | $97,293 | ||
Sale | PHOENIX VENTURE PARTNERS II LP 10 percent owner | Common Stock | 3,100,000 | $4.4 | $13,640,000 | ||
Purchase | REDMILE GROUP, LLC director | Common Stock | 222,222 | $4.5 | $999,999 | ||
Option | SCHIFFMAN GREGORY T officer: Chief Financial Officer | Stock Option (right to buy) | 50,000 | $1.1 | $55,000 | ||
Option | SCHIFFMAN GREGORY T officer: Chief Financial Officer | Common Stock | 50,000 | $1.1 | $55,000 | ||
Purchase | KORMAN SARAH officer: General Counsel | Common Stock | 4,250 | $7.96 | $33,830 | ||
Purchase | BEDRICK TODD officer: VP, CCPAO | Common Stock | 2,000 | $7.5 | $15,000 | ||
Purchase | MCCLAIN SEAN director, officer.. | Common Stock | 7,155 | $6.92 | $49,513 |
| Quarter | Transcript |
|---|---|
| Q1 2024 14 May 2024 | Q1 2024 Earnings Call Transcript |
| Q3 2021 14 Nov 2021 | Q3 2021 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Sean McClain (1990) Founder, Chief Executive Officer, Pres & Director | $410,400 |
Mr. Gregory T. Schiffman CPA, CPA, MBA (1957) Chief Financial Officer | $357,270 |
-
What's the price of Absci stock today?
One share of Absci stock can currently be purchased for approximately $2.65.
-
When is Absci's next earnings date?
Unfortunately, Absci's (ABSI) next earnings date is currently unknown.
-
Does Absci pay dividends?
No, Absci does not pay dividends.
-
How much money does Absci make?
Absci has a market capitalization of 332.50M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.5% to 5.72M US dollars.
-
What is Absci's stock symbol?
Absci Corporation is traded on the NASDAQ under the ticker symbol "ABSI".
-
What is Absci's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Absci?
Shares of Absci can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Absci's key executives?
Absci's management team includes the following people:
- Mr. Sean McClain Founder, Chief Executive Officer, Pres & Director(age: 35, pay: $410,400)
- Mr. Gregory T. Schiffman CPA, CPA, MBA Chief Financial Officer(age: 68, pay: $357,270)
-
Is Absci founder-led company?
Yes, Absci is a company led by its founder Mr. Sean McClain.
-
How many employees does Absci have?
As Jul 2024, Absci employs 155 workers.
-
When Absci went public?
Absci Corporation is publicly traded company for more then 4 years since IPO on 22 Jul 2021.
-
What is Absci's official website?
The official website for Absci is absci.com.
-
Where are Absci's headquarters?
Absci is headquartered at 18105 SE Mill Plain Boulevard, Vancouver, WA.
-
How can i contact Absci?
Absci's mailing address is 18105 SE Mill Plain Boulevard, Vancouver, WA and company can be reached via phone at +36 09491041.
Absci company profile:
Absci Corporation
absci.comExchange:
NASDAQ
Full time employees:
155
Industry:
Biotechnology
Sector:
Healthcare
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
18105 SE Mill Plain Boulevard
Vancouver, WA 98683
Vancouver, WA 98683
CIK: 0001672688
ISIN: US00091E1091
CUSIP: 00091E109
